Clinical Implication of Optical Coherence Tomography-Based Neoatherosclerosis

다국어 초록 (Multilingual Abstract)

Recent research has indicated neoatherosclerosis (NA), the de novo development of atherosclerosis within the neointimal region of the stented segment after coronary stent implantation, as a mechanism of late/very late stent thrombosis (VLST) and restenosis. This research is based on histologic and intravascular imaging studies. Optical coherence tomography (OCT) is an imaging tool that is superior with regard to resolution capacity, and can be used to visualize detailed information about distinct morphological characteristics of the restenotic tissue. Thus, OCT is a valuable imaging tool for examining NA, such as macrophage infiltration, lipid accumulation, in-stent calcification, or neointimal rupture. This article discusses the prevalence, predictors, and clinical implications of NA that can be observed by OCT.

참고문헌 (Reference)

1 Yamaji K, "Very long-term(15 to 20 years)clinical and angiographic outcome after coronary bare metal stent implantation" 3 : 468-475, 2010

2 Amabile N, "Very late stent thrombosis related to incomplete neointimal coverage or neoatherosclerotic plaque rupture identified by optical coherence tomography imaging" 15 : 24-31, 2014

3 Räber L, "Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents : a prospective cohort study" 125 : 1110-1121, 2012

4 Nakazawa G, "The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents" 57 : 1314-1322, 2011

5 Kuroda M, "The impact of in-stent neoatherosclerosis on long-term clinical outcomes : an observational study from the Kobe University Hospital optical coherence tomography registry" 12 : 1366-1374, 2016

6 Tian J, "Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics : optical coherence tomography study" 167 : 884-892, 2014

7 Kim JS, "Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT" 5 : 1147-1155, 2012

8 Yonetsu T, "Predictors for neoatherosclerosis : a retrospective observational study from the optical coherence tomography registry" 5 : 660-666, 2012

9 Lee SY, "Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis" 85 : 564-572, 2015

10 Lee SY, "Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis" 9 : 945-951, 2013

11 Gonzalo N, "Optical coherence tomography patterns of stent restenosis" 158 : 284-293, 2009

12 Ko YG, "Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation" 28 : 715-723, 2012

13 Lee SY, "Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation" 8 : e001878-, 2015

14 Kang SJ, "Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation" 123 : 2954-2963, 2011

15 Karanasos A, "OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold" 64 : 2343-2356, 2014

16 Habara M, "Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study" 14 : 276-284, 2013

17 Taniwaki M, "Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography" 133 : 650-660, 2016

18 Souteyrand G, "Mechanisms of stent thrombosis analysed by optical coherence tomography : insights from the national PESTO French registry" 37 : 1208-1216, 2016

19 Simsek C, "Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold : five-year results of multiple invasive imaging modalities" 11 : 996-1003, 2016

20 Ali ZA, "Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis : multimodality intravascular imaging of drug-eluting and bare-metal stents" 6 : 507-517, 2013

21 Kim C, "Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation" 170 : 591-597, 2015

22 Karanasos A, "Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold : changing the paradigm of coronary stenting?" 126 : 89-91, 2012

23 Prati F, "Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis" 31 : 401-415, 2010

24 Nakazawa G, "Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis" 4 : 38-46, 2011

25 Lee SJ, "Evaluation of neointimal morphology of lesions with or without in-stent restenosis : an optical coherence tomography study" 34 : 633-639, 2011

26 Joner M, "Endothelial cell recovery between comparator polymer-based drug-eluting stents" 52 : 333-342, 2008

27 Habara M, "Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation : an optical coherence tomography study" 4 : 232-238, 2011

28 Vergallo R, "Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography" 112 : 1315-1321, 2013

29 Tearney GJ, "Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation" 59 : 1058-1072, 2012

30 Yonetsu T, "Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography" 110 : 933-939, 2012

31 Stone GW, "Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease : a randomized controlled trial" 294 : 1215-1223, 2005

32 Takano M, "Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography" 55 : 26-32, 2009

33 Levine GN, "ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" 58 : 44-122, 2011

34 Stone GW, "A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease" 350 : 221-231, 2004

35 Windecker S, "2014 ESC/EACTS guidelines on myocardial revascularization : the task force on myocardial revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)" 35 : 2541-2619, 2014